Year archive

Transcenta Holding Limited — 2022 filings

All 118 regulatory filings released by Transcenta Holding Limited (6628) in 2022, sourced directly from the official regulator.

118 Filings

2022 Period

2022 filings (118)

Filing	Released	Lang
Next Day Disclosure Returns Share Issue/Capital Change	2022-12-30	English
Next Day Disclosure Returns Transaction in Own Shares	2022-12-22	English
Next Day Disclosure Returns Transaction in Own Shares	2022-12-20	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-12-19	English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEES Board/Management Information	2022-12-19	English
GRANT OF (I) SHARE OPTIONS; (II) AWARD SHARES; AND (III) RESTRICTED SHARE UNITS Share Issue/Capital Change	2022-12-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-05	English
Next Day Disclosure Returns Transaction in Own Shares	2022-12-01	English
Next Day Disclosure Returns Transaction in Own Shares	2022-11-28	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE Governance Information	2022-11-25	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE Remuneration Information	2022-11-25	English
CONNECTED TRANSACTION IN RELATION TO CANCELLATION OF SHARE OPTIONS AND PROMISSORY NOTES Capital/Financing Update	2022-11-25	English
Next Day Disclosure Returns Transaction in Own Shares	2022-11-18	English
Next Day Disclosure Returns Transaction in Own Shares	2022-11-17	English
Next Day Disclosure Returns Transaction in Own Shares	2022-11-16	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-15	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-14	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-11	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY'S PRESENTATION OF TWO SCIENTIFIC POSTERS AT SITC 2022 MEETING Regulatory Filings	2022-11-11	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-10	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-09	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-08	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-07	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 4 NOVEMBER 2022 Declaration of Voting Results & Voting Rights Announcements	2022-11-04	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-04	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-03	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
(Revised) Next Day Disclosure Return Transaction in Own Shares	2022-11-02	English
Next Day Disclosure Return Transaction in Own Shares	2022-11-01	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-31	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-28	English
VOLUNTARY ANNOUNCEMENT-CANCELLATION OF SHARE OPTIONS AND PROMISSORY NOTES Capital/Financing Update	2022-10-27	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-24	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY TO PRESENT FIRST-IN-CLASS TST003 ANTIBODY PROGRAM AT THE TENTH TEMTIA MEETING Regulatory Filings	2022-10-24	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-21	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-20	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-19	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-18	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-17	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2022-10-16	English
SHARE INCENTIVE SCHEME Regulatory Filings	2022-10-16	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, NOVEMBER 4, 2022 Proxy Solicitation & Information Statement	2022-10-16	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-10-16	English
PROPOSED AMENDMENT TO THE POST-IPO SHARE AWARD SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2022-10-16	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-14	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY TO PRESENT TWO SCIENTIFIC POSTERS AT SITC 2022 ANNUAL MEETING Regulatory Filings	2022-10-14	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-13	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-12	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-11	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-10	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-07	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-06	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON IND CLEARANCE FROM FDA FOR ITS BEST-IN-CLASS MASP2 TARGETING ANTIBODY TST004 FOR THE TREATMENT OF IGA NEPHROPATHY Regulatory Filings	2022-10-05	English
Next Day Disclosure Return Transaction in Own Shares	2022-10-03	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-30	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-29	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-28	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-27	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-26	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2022-09-26	English
2022 INTERIM REPORT Interim / Quarterly Report	2022-09-26	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-23	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-22	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-21	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-20	English
Next Day Disclosure Return Transaction in Own Shares	2022-09-14	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON IND CLEARANCE FROM FDA FOR ITS FIRST-IN-CLASS GREMLIN1 TARGETING ANTIBODY TST003 FOR THE TREATMENT OF SOLID TUMORS Regulatory Filings	2022-09-14	English
VOLUNTARY ANNOUNCEMENT-INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE Transaction in Own Shares	2022-09-14	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY TO RELEASE ENCOURAGING INTERIM SAFETY AND EFFICACY DATA OF THE TST001 (OSEMITAMAB) AND CHEMOTHERAPY COMBINATION EXPANSION COHORT FOR FIRST LINE CLAUDI Capital/Financing Update	2022-09-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report	2022-08-29	English
DATE OF BOARD MEETING Regulatory Filings	2022-08-16	English
SUPPLEMENTAL VOLUNTARY ANNOUNCEMENT-CHANGE OF THE CHIEF MEDICAL OFFICER Board/Management Information	2022-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Share Issue/Capital Change	2022-08-03	English
VOLUNTARY ANNOUNCEMENT-CHANGE OF THE CHIEF MEDICAL OFFICER Board/Management Information	2022-08-02	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG AND CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE Regulatory Filings	2022-07-20	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-07-20	English
RESIGNATION OF EXECUTIVE DIRECTOR Board/Management Information	2022-07-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-06	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY BEING SELECTED TO PRESENT THE PRECLINICAL DATA OF TST004 AT THE 2022 ISN FRONTIERS MEETINGS OF COMPLEMENT RELATED KIDNEY DISEASES Regulatory Filings	2022-06-28	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-06-27	English
ANNOUNCEMENT-THE PASSING AWAY OF EXECUTIVE DIRECTOR AND JOINT COMPANY SECRETARY Board/Management Information	2022-06-27	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 10 JUNE 2022 Declaration of Voting Results & Voting Rights Announcements	2022-06-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-06	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COMPANY'S PUBLICATION OF PHASE I CLINICAL DATA OF TST001 IN COMBINATION WITH CAPOX AS THE FIRST LINE TREATMENT OF ADVANCED AND METASTATIC G/GEJ CANC Regulatory Filings	2022-06-02	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON NATURE CANCER'S PUBLICATION OF THE COLLABORATIVE STUDY RESULTS BY THE COMPANY AND SHANGHAI JIAO TONG UNIVERSITY SCIENTISTS ON THE POTENTIAL APPLICATION O Regulatory Filings	2022-05-31	English
NOTIFICATION LETTER AND REQUEST FORM TO SHAREHOLDERS (NOTIFICATION OF PUBLICATION OF 2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT OF THE COMPANY) Report Publication Announcement	2022-05-26	English
2021 Environmental, Social and Governance Report Environmental & Social Information	2022-05-26	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 10 JUNE 2022 AGM Information	2022-05-12	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-05-12	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-05-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON PRESENTATION OF CLINICAL TRIAL DATA OF TST001 AND MSB0254 AT 2022 ASCO ANNUAL MEETING Regulatory Filings	2022-04-29	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON THE FIRST PATIENT DOSED IN CHINA STUDY OF ANTI-SCLEROSTIN MONOCLONAL ANTIBODY TST002 FOR THE TREATMENT OF OSTEOPOROSIS Regulatory Filings	2022-04-28	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2022-04-27	English
2021 ANNUAL REPORT Annual Report	2022-04-27	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON SUCCESSFULLY PASSING THE AUDIT OF EU QUALIFIED PERSON FOR THE MANUFACTURING OF TST001 Regulatory Filings	2022-04-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Regulatory Filings	2022-04-06	English
VOLUNTARY ANNOUNCEMENT-GLOBAL CLINICAL COLLABORATION WITH BRISTOL MYERS SQUIBB TO EVALUATE TST001 IN COMBINATION WITH OPDIVO IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC/GASTROESOPHAGE Regulatory Filings	2022-03-22	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-03-21	English
(1) APPOINTMENT OF EXECUTIVE DIRECTOR; AND (2) APPOINTMENT OF SECRETARY TO THE BOARD Board/Management Information	2022-03-21	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021 Annual Report	2022-03-21	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON THE PRESENTATION OF SAFETY/ TOLERABILITY AND PRELIMINARY ANTI-TUMOR ACTIVITY DATA IN GASTRIC AND PANCREATIC CANCERS OF TST001 MONOTHERAPY FROM CHINA PHAS Regulatory Filings	2022-03-10	English
DATE OF BOARD MEETING Report Publication Announcement	2022-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Regulatory Filings	2022-03-03	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON THE FIRST PATIENT DOSED IN THE PHASE IIA STUDY OF CLAUDIN18.2 MONOCLONAL ANTIBODY TST001 COMBINED WITH CISPLATIN AND GEMCITABINE FOR THE FIRST LINE TREATMENT Regulatory Filings	2022-02-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Regulatory Filings	2022-02-08	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON PHASE I CLINICAL TRIAL FOR TST001 FOR PRESENTATIONS AT 2022 ASCO GI AND IGCC Regulatory Filings	2022-01-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Regulatory Filings	2022-01-06	English
GRANT OF RESTRICTED SHARE UNITS PURSUANT TO THE PRE-IPO EQUITY INCENTIVE PLAN Director's Dealing	2022-01-03	English